American Cancer Society Issues New Guidelines Recommending Routine Prostate Cancer Screening
The American Cancer Society has updated its guidelines to recommend routine prostate-specific antigen blood tests every two years for men aged 50 to 69, marking a notable shift in screening policy.
❤️Conditions & CarePhoto: The New York Times Health
Key points
- ACS recommends biennial P.S.A. screening for men aged 50 to 69.
- Black men and those with a family history are advised to start annual screening at age 45.
- Experts caution that routine screening could still lead to unnecessary biopsies and treatment harms.
The American Cancer Society (ACS) has released updated guidance advising that all men between the ages of 50 and 69 undergo regular prostate cancer screening every two years using a blood test. Under the new recommendations, Black men and individuals with a strong family history of the disease should begin annual screenings at age 45, reflecting significant health disparities in diagnoses and mortality rates.
This update represents a departure from earlier advice that left the decision entirely up to individual patients and physicians following a discussion of risks and benefits. Universal screening for prostate cancer has historically sparked debate due to the limitations of prostate-specific antigen (P.S.A.) testing and the potential harms of diagnosing slow-growing tumors that may never threaten a patient's life. While the ACS points to long-term European trial data showing a modest reduction in prostate cancer deaths and fewer metastatic cases, some clinical experts express concern that the new stance might encourage routine testing without adequate shared decision-making.
What to know: The updated ACS guidelines suggest biennial P.S.A. blood tests for men aged 50 to 69, and annual testing starting at age 45 for Black men or those with a strong family history. Although advocates cite modern diagnostic refinements like MRIs and active surveillance as ways to minimize harms, critics worry about the potential for over-testing and overtreatment. Readers should consult a qualified physician to discuss personal risk factors and make informed screening decisions.
Source The New York Times Health — nytimes.com/2026/11/12/well/prostate-cancer-screening-guideline.html ↗
Read next
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🧠Mind & Mental HealthThe Role of Daily Mobility Training in Managing Sedentary Tension
A two-week personal trial suggests that incorporating short, daily mobility exercises may help alleviate stiffness associated with sedentary desk work. Experts note that …
🧠Mind & Mental HealthNew Theoretical Framework Explores Memory Formation and Dementia
Researchers have proposed a new model suggesting the brain's limbic system functions similarly to generative AI, potentially offering a new way to understand and classify…